GLENMEDE TRUST CO NA - OSIRIS THERAPEUTICS INC NEW ownership

OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 55 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q2 2013. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of OSIRIS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2016$0710.0%0.00%
Q4 2015$0
-100.0%
710.0%0.00%
Q3 2015$1,000
-98.7%
71
-98.4%
0.00%
-100.0%
Q1 2015$79,000
+11.3%
4,5000.0%0.00%0.0%
Q4 2014$71,000
+26.8%
4,5000.0%0.00%
Q3 2014$56,000
-20.0%
4,5000.0%0.00%
-100.0%
Q2 2014$70,000
+9.4%
4,500
-8.2%
0.00%0.0%
Q1 2014$64,000
-17.9%
4,9000.0%0.00%0.0%
Q4 2013$78,000
-12.4%
4,900
-9.3%
0.00%0.0%
Q3 2013$89,000
+64.8%
5,4000.0%0.00%0.0%
Q2 2013$54,0005,4000.00%
Other shareholders

There were no reported owners of OSIRIS THERAPEUTICS INC NEW in Q2 2013.

NameSharesValueWeighting ↓
View complete list of OSIRIS THERAPEUTICS INC NEW shareholders